Background Preeclampsia presents a highly prevalent burden on pregnant women with an
estimated incidence of 2% to 5%. Preeclampsia increases the maternal risk of death 20-fold …

Background Hypertensive disorders of pregnancy are a leading cause of maternal and
perinatal morbidity and mortality. If women at high risk for developing complications could be …

Objective To assess the performance of placental, fetal and maternal cardiovascular
markers in the prediction of adverse perinatal and maternal outcomes in women with …

The sFlt-1 (soluble fms-like tyrosine kinase-1)/PlGF (placental growth factor) ratio is a helpful
tool for the prediction and diagnosis of preeclampsia (PE). Current data even show that the …

Purpose An elevated soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor
(PlGF) ratio is associated with adverse perinatal outcome (APO) and the mean time until …

Objectives Angiogenic marker assessment, such as the ratio of soluble fms‐like tyrosine
kinase‐1 (sFlt‐1) to placental growth factor (PlGF), is known to be a useful tool in the …

Objectives We aimed to determine whether a high ratio of soluble fms-like tyrosine kinase-1
(sFlt-1) to placental growth factor (PlGF) would be associated with serious negative …

Background Preeclampsia remains the leading cause of maternal morbidity and mortality.
Consequently, research has focused on validating tools to predict maternal outcomes …

Objective: The concentration of the placental circulating factor in early pregnancy is often
extremely low, and the traditional prediction method cannot meet the clinical demand for …

Диагностика преэклампсии в клинической практике вызывает определенные
трудности, обусловленные неспецифичностью симптомов, полиформизмом …